Wound healing outcomes in diabetic kidney disease patients receiving SGLT2 inhibitor therapy: a prospective propensity score-matched cohort study
Rong-rong Zhang, Siyue Huang, Xinjie Wang, Xiaoqin Li · 2026
Read Wound healing outcomes in diabetic kidney disease patients receiving SGLT2 inhibitor therapy: a prospective propensity score-matched cohort study by Rong-rong Zhang, Siyue Huang, Xinjie Wang, Xiaoqin Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13271949.txt.
Description
Rong-rong Zhang and coauthors follow in 2026 wound healing in people with diabetic kidney disease who take SGLT2 inhibitor drugs. These drugs protect heart and kidneys, yet sugar in the urine raised worry that wounds might heal more slowly. Clinicians lacked direct evidence for patients with active wounds.
The study enrolled 247 adults at a wound care center and matched 102 drug users with 102 similar non-users. Median healing time was nearly identical, at about thirty-three days in both groups. Infection and kidney outcomes at six months also showed no clear difference. The results ease concern about continuing these drugs during wound care.
Catalog record
| CREATOR | Rong-rong Zhang, Siyue Huang, Xinjie Wang, Xiaoqin Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |